Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators.
about
How do messenger RNA splicing alterations drive myelodysplasia?Exploiting differential RNA splicing patterns: a potential new group of therapeutic targets in cancer.The cancer-associated U2AF35 470A>G (Q157R) mutation creates an in-frame alternative 5' splice site that impacts splicing regulation in Q157R patients.The Augmented R-Loop Is a Unifying Mechanism for Myelodysplastic Syndromes Induced by High-Risk Splicing Factor Mutations.
P2860
Distinct splicing signatures affect converged pathways in myelodysplastic syndrome patients carrying mutations in different splicing regulators.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Distinct splicing signatures a ...... different splicing regulators.
@en
type
label
Distinct splicing signatures a ...... different splicing regulators.
@en
prefLabel
Distinct splicing signatures a ...... different splicing regulators.
@en
P2093
P2860
P50
P356
P1433
P1476
Distinct splicing signatures a ...... different splicing regulators.
@en
P2093
Arnold Ganser
Dong-Er Zhang
Felicitas Thol
Jinsong Qiu
Liang Chen
Michael Heuser
Rafael Bejar
P2860
P304
P356
10.1261/RNA.056101.116
P407
P577
2016-08-04T00:00:00Z